|
RAB18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.622200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.235000E-01 |
| Normal-vs-Stage2 |
6.185900E-02 |
| Normal-vs-Stage3 |
9.096200E-02 |
| Normal-vs-Stage4 |
6.857500E-03 |
| Stage1-vs-Stage2 |
2.780000E-01 |
| Stage1-vs-Stage3 |
3.396400E-01 |
| Stage1-vs-Stage4 |
6.330000E-02 |
| Stage2-vs-Stage3 |
7.260400E-01 |
| Stage2-vs-Stage4 |
5.352000E-01 |
| Stage3-vs-Stage4 |
2.898200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.279370E-01 |
| Normal-vs-AfricanAmerican |
9.612000E-01 |
| Normal-vs-Asian |
1.060620E-01 |
| Caucasian-vs-AfricanAmerican |
4.061400E-01 |
| Caucasian-vs-Asian |
5.504600E-01 |
| AfricanAmerican-vs-Asian |
2.862400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.832500E-02 |
| Normal-vs-Female |
1.178390E-01 |
| Male-vs-Female |
3.304400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.193200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.599700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.033600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.575410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.650000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.614300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.992600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.180000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.210400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.739800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.984200E-01 |
| Classical-VS-Follicular |
2.169400E-04 |
| Classical-VS-Other |
4.694800E-01 |
| Classical-VS-Normal |
5.679200E-01 |
| Tall-VS-Follicular |
2.086500E-02 |
| Tall-VS-Other |
4.382200E-01 |
| Tall-VS-Normal |
5.678400E-01 |
| Follicular-VS-Other |
6.028200E-01 |
| Follicular-VS-Normal |
8.649500E-04 |
| Other-VS-Normal |
2.885600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.121600E-02 |
| Normal-vs-N1 |
1.826220E-01 |
| N0-vs-N1 |
5.642600E-01 |
|
|
